These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2376324)

  • 61. The effects of Mindfulness Meditation on hallucination and delusion in severe schizophrenia patients with more than 20 years' medical history.
    Sheng JL; Yan Y; Yang XH; Yuan TF; Cui DH
    CNS Neurosci Ther; 2019 Jan; 25(1):147-150. PubMed ID: 30264927
    [No Abstract]   [Full Text] [Related]  

  • 62. Prognosis and outcome using broad (DSM-II) and narrow (DSM-III) concepts of schizophrenia.
    Westermeyer JF; Harrow M
    Schizophr Bull; 1984; 10(4):624-37. PubMed ID: 6515337
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Positive or negative symptoms. Which are more reliable in the diagnosis of schizophrenia?].
    Klosterkötter J; Albers M; Steinmeyer EM; Hensen A; Sass H
    Nervenarzt; 1994 Jul; 65(7):444-53. PubMed ID: 7800088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Preliminary report.
    Kingdon DG; Turkington D
    J Nerv Ment Dis; 1991 Apr; 179(4):207-11. PubMed ID: 2007891
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Initial assessment of hospital treatment by patients with paranoid schizophrenia: a predictor of outcome.
    Bröker M; Röhricht F; Priebe S
    Psychiatry Res; 1995 Sep; 58(1):77-81. PubMed ID: 8539314
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive behavioral therapy in the treatment of schizophrenia.
    Turkington D; Dudley R
    Expert Rev Neurother; 2004 Sep; 4(5):861-8. PubMed ID: 15853512
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The treatment of acute psychosis without neuroleptics: six-week psychopathology outcome data from The Soteria Project.
    Mosher LR; Vallone R; Menn A
    Int J Soc Psychiatry; 1995; 41(3):157-73. PubMed ID: 8847197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia].
    Loas G; Noisette C; Legrand A; Boyer P; Delahousse J
    Encephale; 1996; 22(5):351-8. PubMed ID: 9035991
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discrimination between and among schizophrenics and other pathologies using a Spanish version of the Whitaker Index of Schizophrenic Thinking.
    Godoy JF; Fernandez M; Muela JA; Roldan G; Catena A; Puente AE
    J Clin Psychol; 1994 Mar; 50(2):158-61. PubMed ID: 8014238
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project.
    Bola JR; Mosher LR
    J Nerv Ment Dis; 2003 Apr; 191(4):219-29. PubMed ID: 12695732
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A concept of social support for acute schizophrenic patients. Time series analysis of daily fluctuations of psychotic markers].
    Aebi E; Ackermann K; Revenstorf D
    Z Klin Psychol Psychopathol Psychother; 1993; 41(1):18-30. PubMed ID: 8511951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode.
    Peuskens J; Kaufman L; Van Vleymen B
    Schizophr Res; 2007 Sep; 95(1-3):169-73. PubMed ID: 17630255
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease.
    Höflich G; Kasper S; Burghof KW; Scholl HP; Möller HJ
    Biol Psychiatry; 1995 Jun; 37(12):892-4. PubMed ID: 7548464
    [No Abstract]   [Full Text] [Related]  

  • 75. Phase-specific psychosocial interventions for first-episode schizophrenia.
    Miller R; Mason SE
    Bull Menninger Clin; 1999; 63(4):499-519. PubMed ID: 10589141
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Befriending patients with medication-resistant schizophrenia: can psychotic symptoms predict treatment response?
    Samarasekera N; Kingdon D; Siddle R; O'Carroll M; Scott JL; Sensky T; Barnes TR; Turkington D
    Psychol Psychother; 2007 Mar; 80(Pt 1):97-106. PubMed ID: 17346383
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The course of psychosis in early phases of schizophrenia.
    Harrow M; Carone BJ; Westermeyer JF
    Am J Psychiatry; 1985 Jun; 142(6):702-7. PubMed ID: 4003589
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Are co-therapies indicated in schizophrenia?].
    Guillibert E; Nomber M
    Ann Med Psychol (Paris); 1992; 150(4-5):307-9. PubMed ID: 1343540
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
    Müller MJ; Wetzel H; Eich FX; Rein W; Puech A; Benkert O;
    J Clin Psychopharmacol; 2002 Dec; 22(6):554-60. PubMed ID: 12454554
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of group music activity as an adjunctive therapy on psychotic symptoms in patients with acute schizophrenia.
    Peng SM; Koo M; Kuo JC
    Arch Psychiatr Nurs; 2010 Dec; 24(6):429-34. PubMed ID: 21111297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.